Characterization of Human Endogenous Retroviral Elements in the Blood of HIV-1-Infected Individuals
Open accessAbstract
We previously reported finding the RNA of a type K human endogenous retrovirus, HERV-K (HML-2), at high titers in the plasma of HIV-1-infected and cancer patients (R. Contreras-Galindo et al., J. Virol. 82:9329–9236, 2008.). The extent to which the HERV-K (HML-2) proviruses become activated and the nature of their activated viral RNAs remain important questions. Therefore, we amplified and sequenced the full-length RNA of the env gene of the type 1 and 2 HERV-K (HML-2) viruses collected from the plasma of seven HIV-1-infected patients over a period of 1 to 3 years and from five breast cancer patients in order to reconstruct the genetic evolution of these viruses. HERV-K (HML-2) RNA was found in plasma fractions of HIV-1 patients at a density of ∼1.16 g/ml that contained both immature and correctly processed HERV-K (HML-2) proteins and virus-like particles that were recognized by anti-HERV-K (HML-2) antibodies. RNA sequences from novel HERV-K (HML-2) proviruses were discovered, including K111, which is specifically active during HIV-1 infection. Viral RNA arose from complete proviruses and proviruses devoid of a 5′ long terminal repeat, suggesting that the expression of HERV-K (HML-2) RNA in these patients may involve sense and antisense transcription. In HIV-1-infected individuals, the HERV-K (HML-2) viral RNA showed evidence of frequent recombination, accumulation of synonymous rather than nonsynonymous mutations, and conserved N-glycosylation sites, suggesting that some of the HERV-K (HML-2) viral RNAs have undergone reverse transcription and are under purifying selection. In contrast, HERV-K (HML-2) RNA sequences found in the blood of breast cancer patients showed no evidence of recombination and exhibited only sporadic viral mutations. This study suggests that HERV-K (HML-2) is active in HIV-1-infected patients, and the resulting RNA message reveals previously undiscovered HERV-K (HML-2) genomic sequences.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Recent studies have provided evidence of frequent recombination of HERV-K (HML2) proviruses and accumulation of synonymous mutations in individuals infected with HIV-1, suggesting purifying selection of HERV-K(HML2) mutants or recombinants.
“Indeed, recent studies have provided evidence of frequent recombination of HERV-K (HML2) proviruses and accumulation of synonymous mutations in individuals infected with HIV-1, suggesting purifying selection of HERV-K(HML2) mutants or recombinants 87.”
From Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis (2013) · cites this paper as [87]
Increased transcriptional levels such as observed following HIV-1 infection might be expected to favor recombination.
“Increased transcriptional levels such as have been observed following HIV-1 infection might be expected to favor recombination 87.”
From Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis (2013) · cites this paper as [87]
Cites
Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans
Barbulescu, M., Turner, G., Seaman, M. I., Deinard, A. S., Kidd, K. K., & Lenz, J. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80390-x · Cited by 244 · cited 5× · see citing works
“However, the 5= LTR of K111 is 27 bp different from the corresponding LTR of the provirus K105, as is the 3= LTR by 15 bp. Sequences flanking the 5= and 3= LTRs of K111 and K105 are only 90% similar, suggesting that these viruses are integrated at different locations and hence are separate viruses.”
BackgroundMethodInfluentialDewannieux, M., Blaise, S., & Heidmann, T. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15573-15577.2005 · Cited by 137 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Hohn, O., Hanke, K., & Bannert, N. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00246 · Cited by 196 · see citing works
“Subsequently, it was even possible to observe virus-like particles by electron microscopy and by immunostaining using HERV-K Env and Gag specific antibodies (116).”
BackgroundAre human endogenous retroviruses pathogenic? An approach to testing the hypothesis
Young, G. R., Stoye, J. P., & Kassiotis, G. (2013) · BioEssays · doi:10.1002/bies.201300049 · Cited by 78 · see citing works
“Increased transcriptional levels such as have been observed following HIV-1 infection might be expected to favor recombination [87].”
Background
- Authors
- Contreras-Galindo, R., Kaplan, M. H., Contreras-Galindo, A. C., Gonzalez-Hernandez, M. J., Ferlenghi, I., Giusti, F., Lorenzo, E., Gitlin, S. D., Dosik, M. H., Yamamura, Y., & Markovitz, D. M.
- Affiliations
- University of Michigan (US)
- Stony Brook University (US)
- Novartis (Italy) (IT)
- Ponce Health Sciences University (PR)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2012-01
- Volume
- 86
- Issue
- 1
- Pages
- 262-276
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC3255917
- OpenAlex
- W2063547657
- Cited by
- 103
- References
- 2
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 1 · 2021: 3 · 2020: 6 · 2019: 8 · 2018: 9 · 2017: 8 · 2016: 9 · 2015: 14 · 2014: 13 · 2013: 11 · 2012: 6
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5g12rr003050-25)
- National Cancer Institute (R01CA144043)
- National Institute of Allergy and Infectious Diseases (R01AI062248)
- National Center for Research Resources (G12-RR03050, G12 RR-003050)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Chromosomal and Genetic Variations
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- HERV-K(HML-2), human endogenous retroviruses, HIV-1 infection, viral RNA, env gene, virus-like particles, breast cancer, recombination, synonymous mutations, purifying selection, N-glycosylation sites, reverse transcription, antisense transcription, long terminal repeat
- MeSH terms
- Humans, Molecular Sequence Data, Phylogeny, Recombination, Genetic, RNA, Viral, HIV-1, HIV Infections, Genome, Viral, Endogenous Retroviruses, Reverse Transcription, env Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review